2.2. Characteristics of the Percentage of Selected Populations of Immune Cells Expressing TLR2 and Soluble Toll-like Receptor 2 (sTLR2) Concentration in the Plasma of Patients with HD in Relation to the Control Group. This evidence concerns the gene TLR2 and Huntington disease.